Crohn Disease Clinical Trials in Washington D.C., District of Columbia
3 recruitingWashington D.C., District of Columbia
Showing 1–3 of 3 trials
Recruiting
Phase 1
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Therapeutic Endpoint in Pediatric IBD Conditions
Inflammatory Bowel DiseasesCrohn DiseaseColitis Ulcerative
Children's National Research Institute60 enrolled1 locationNCT06065228
Recruiting
Not Applicable
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Crohn DiseaseUlcerative Colitis
University of California, San Diego250 enrolled22 locationsNCT05230173